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Persistent polychlorinated biphenyl (PCB) metabolites were studiedwith respect to their inter-
action with the human glucocorticoid receptor (GR). 3-Methylsulphonyl-2,5,6,2',4',5'-hexa-
chiorobiphenyl (3-MeSOr-CB149) was shown to compete with 3H-dexametbasone for binding
to theGR, with an IC50 (concentration thatinhibits 50%) ofapproately 1 pM. UsingGRAF
cells expressing human GR, glucocorticoid responsive element, and a reporter enzyme, we
demonstrated that 3-MeSO2-CB149 fimctionally acts as an antagonist at the GR (IC50 m 2.7
pM). In accordancewiththe receptorbinding, the anagoniism mainlyappeared to be ofacom-
petitive nature. When studying thecompetitive binding of24 methylsulfonyl PCBs (relative to
dezamethasone) to GRfrom mouse livercyrosol, seven compounds had a higheraffinity to GR
than 3-MeSO2-CBI49. Structure-activity relationship studies indicated that the presence of
three chlorineatonms inthe ortho-position andchlorineand methylsulfone groupsoneitherend
ofthe molecule (4 and 4'-position) inased the affinity to GR. The relevce ofthis finding
for human health is not known, but PCB methyl suifones are ubiquitous pollutants present in
mother'smilk. Theresults tresstheneedforstudyingendocrinedisruptors thataficthormonal
systems otherthan sexandthyroidogenichormones. Keywork endocrinedisruptor, glucocorti-
coid receptor, methyl sulphone, PCB, polychlorinated biphenyls, xenobiotic. Environ Health
Penect106:769-772 (1998). [Online 12November 1998]
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A lot of attention has been focused on the
ability of environmental pollutants to affect
estrogen homeostasis, e.g., by binding to the
estrogen receptor as agonists or antagonists,
thereby affecting the sex differentiation of
organisms (1,4. Little concern has been paid
to the ability ofpollutants to interfere with
other steroid hormone receptors such as the
glucocorticoid receptor (GR), although ben-
zpyrene, for example, has been shown to
affect the GRdensity in rats (3).
The decreasing populations ofgray seals
(Halichoerus grypus) and harbor seals (Phoca
vitulina) from the heavily polluted Baltic
Sea suffer from a disease syndrome suggest-
ed to be caused by an increased exposure to
glucocorticoid hormones (hyperadrenocorti-
cism) (4). The syndrome is characterized by
claw deformations, skin abnormalities,
adrenocortical hyperplasias, osteoporosis,
uterine lesions, and an impaired immune
system. However, the two most abundant
pollutants in the Baltic, i.e., polychlorinated
biphenyls (PCBs) and dichlorodiphenyl
dichloroethylene (DDE), have not been
shown to elicit all these effects in anyexperi-
mental animals. A possible explanation for
some ofthese symptoms is that environmen-
tal pollutants may act as glucocorticoid ago-
nists or antagonists, thereby interrupting
glucocorticoid homeostasis in the animals.
The present study was undertaken to
investigate if environmental pollutants have
affinity to the GR or interfere with the glu-
cocorticoid signaling pathway. We used
human and mouse GRs for the binding
studies and a well-defined cellular system
(human GR and GR responsive elements
transfected into CHO cells) for effect stud-
ies. As prototype chemicals, some methyl-
sulfone metabolites ofPCBs and DDEwere
chosen. Methylsulfonyl PCBs are the third
most abundant pollutants in, for example,
Scandinavian and Canadian biota (5), but
are still seldom studied with respect to bio-
logical effects. 3-Methylsulfonyl DDE is an
adrenocortical toxicant following metabolic
activation by asteroid (CYP 1iB1) hydroxy-
lase (6). The effects ofthe xenobiotics were
compared with that ofRU486, a drug that
acts as a competitive antagonist at the GR.
RU486 inhibits cortisol-dependent func-
tions in vivo in humans, which, due to the
feed-back systems, increases the plasma lev-
els of adrenocorticotropic hormone
(ACTH) andcortisol (7,8).
Materials and Methods
Reagents andsupplies. The used methylsul-
fonyl PCBs and 3-methylsulfonyl DDE (3-
MeSO2-DDE) (see Table 1) were synthesized
according to Bergman and Wachtmeister
(9,10) and Haraguchi et al. (11). 3H-Dexa-
methasone (40 Ci/mmol) waspurchased from
Amersham International (Buckinghamshire,
UK). Dexamethasone, molybdic acid, bovine
serum albumin, and dimethyl sulfoxide
(DMSO) were obtained from Sigma (St.
Louis, MO). 1,4-Dithio-DL-threitol (D1T),
EDTA, and potassium phosphate were from
Fluka (Buchs, Switzerland). RU486 was a
kind gift from Roussel Uclaf (Paris, France).
Ham's F12 medium, L-glutamine, fetal calf
serum (FCS), and gentamicin were pur-
chased from Gibco BRL/Life Technologies
(Thby, Sweden), phenol red-free Coon's/F12
medium was prepared by SVA (Uppsala,
Sweden), and SRC 3000 serum substitute
was purchased from Tissue Culture Services
(Botolph Claydon, Buckingham, UK). The
chemiluminescence substrate AMPPD was
purchased from Tropix (Boston, MA), via
Boule Diagnostics (Huddinge, Sweden). The
CellTiter 96 Cell Proliferation kit was pur-
chased from Promega via Scandinavian
Diagnostics Services (Falkenberg, Sweden).
White microtitration plates were obtained
from Dynatech Laboratories via In Vitro AB
(Stockholm, Sweden), and Costar cell cul-
ture plastics were purchased from Life
Technologies (Taby, Sweden). All plastics
used for binding studies with GR were of
polypropylen. The graphs were drawn using
the computer program KaleidaGraph
(SynergySoftware, Reading, PA).
Preparation ofGR. Human GR was
extracted from insect cells infected with
recombinant baculovirus encodingfrill-length
human GR The cells were homogenized in
phosphate buffer (20 mM, pH 8.0) contain-
ing 1 mM EDTA, 100 mM KCl, 20 mM
MoO4, 8.8% glycerol, and 2 mM DTT. The
homogenate was centrifuged at 8,000g, and
the resulting GR-containing supernatant was
stored at -70°C until used. Mouse liver was
homogenized as described above and the
homogenate was centrifuged at 100,000gfor
1 hr. The resulting GR-containing cytosol
was storedat-700Cuntilused.
Competition binding studies with GR.
GR (1 nmol, as determined by saturation
studies), 3H-dexamethasone (5 nM), and
increasing concentrations ofDDE- and PCB
methyl sulfones (1 nM-30 pM in DMSO)
were incubated overnight on ice in the
buffer used for extraction of GR (modified
to contain 10% glycerol and 1 mM DTT).
Free 3H-dexamethasone was separated from
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Table 1. The inhibitory effects of PCB methyl sulfones c
assays using 3H-dexamethasone and mouse liver cyl
receptor (GR)
Compound lC2
4-MeSO2-2,3,6,2',4',5'-hexaCB (4-MeSO2-CB49)
4-MeSO2-2,5,6,2',4'-pentaCB (4-MeSO2-CB91)
4-MeSO2-2,3,6,2',3',4'-hexaCB (4-MeSO2-CB132)
4-MeSO2-2,3,6,2',3',4',5'-heptaCB (4-MeSO2-CB174)
4-MeSO2-2,3,6,3',4'-pentaCB (4-MeSO2-CB 3710)
4-MeSO2-2,3,6,4'-tetraCB (4-MeSO2-CB64)
4-MeSO2-2,5,2',4'-tetraCB (4-MeSO2-CB49)
4-MeSO2-2,5,2',5'-tetraCB (4-MeSO2-CB52)
4-MeSO2-2,5,3',4'-tetraCB (4-MeSO2-CB75)
4-MeSO2-2,5,2',3',4'-pentaCB (4-MeSO2-CB87)
4-MeSO2-2,5,2',4',5'-pentaCB (4-MeSO2-CB181)
4-MeSO2-2,5,2',3',4',5'-hexaCB (4-MeSO2-CB141)
3-MeSO2-2,5,6,2',3',4',5'-heptaCB (3-MeSO2-CB174)1
3-MeSO2-2,5,6,2',4'-pentaCB (3-MeeSO2-CB91) 1
3-MeSO2-2,5,6,2',3',4'-hexaCB (3-MeSO2-CB132) 1
3-MeSO2-2,5,6,2',4',5'-hexaCB (3-MeSO2-CB149) 1
3-MeSO2-2,5,6,3',4'-pentaCB (3-MeSO2-CB1410)
3-MeSO2-2,5,6,4'-tetraCB (3-MeSO2-CB64)
3-MeSO2-2,5,2',4'-tetraCB (3-MeSO2-CB49)
3-MeSO2-2,5,2',5'-tetraCB (3-MeSO2-CB52)
3-MeSO2-2,5,3',4'-tetraCB (3-MeSO2-CB75)
3-MeSO2-2,5,2',3',4'-pentaCB (3-MeSO2-CB87)
3-MeSO2-2,5,2',4',5'-pentaCB (3-MeSO2-CB11)
3-MeSO2-2,5,2',3',4',5'-hexaCB (3-MeSO2-CB141)
Abbreviations: IC25, concentration that inhibits 25%; IC5, cO
50%; CB, chlorinated biphenyl; NI, no inhibition, i.e., the comp
GR at the doses tested. The values shown are mean ± stanc
range (n= 2).
GR-bound 3H-dexamethasone by elution
through a Sephadex column (QS-2A, Boule
Diagnostics AB, Huddinge, Sweden). 3H-
dexamethasone bound to GRwas measured
by liquid scintillation of the protein phase.
The dissociation constants (Kd) for the
binding of3H-dexamethasone to human
and mouse GRwere 5-10 nM.
Cell culure. The GRAF reporter cell line
was generated by stable transformation of
Chinesehamsterovarycells (CHO KI,ATCC
No. CCL 61) with the mammalian expression
vector pmT-hGR (12) and the glucocorticoid
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Figure 1. Competition binding studies to the human
glucocorticoid receptor (GR). Receptor (1 nmol)
was incubated overnight with 3H-dexamethasone
(Dex) and either 3-MeSO2-CB149, 3-MeSO2-CB101,
3-MeSO2-DDE, or unlabeled Dex, after which 3H-
Dex bound to GR was quantified. Each point repre-
sentsthe mean ofduplicate samples.
responsive reportervector
in competition binding MMTV-ALP (13). GRAF
tosolic glucocorticoid cells were routinely cul-
tured in Ham's F12
25(PM) lC50(PM) medium supplemented
5±4 15±6 with 10% FCS and 2
7 ± 4 17 ±6 P1M L-glutamine (in
9 5 17 ±4 370C humidified cham-
6-8 16-18 bersat5%C02).
NI StudiesofGR-mediated
NI effects in GRAF cells.
NI Before each experiment,
NI the GRAF cells were
NI seeded in 96-well tissue
NI culture plates (approxi-
NI1 2020 mately 25 x 103 cells/
2-13 >30 well) in phenol red-free
-18 >30 Ham s F12 medium
8-20 >30 supplemented with 10%
NI FCS (stripped with dex-
NI tran-coated charcoal), 2
NI pM L-glutamine, and NI gentamicin (50 jg/ml).
NI NI On day 2 cells were
NI rinsed with Coon's/F12
NI medium supplemented
ncentration that inhibits with 5% SRC 3000, 2
ound lacks affinitytothe pM L-glutamine, and
dard deviation (n = 3) or gentamicin (50 pg/ml),
andweregiven 100p1 of
the same medium sup-
plemented with dexamethasone and xenobi-
otics (1 nM-l0 pM) at various concentra-
tions. In all experiments, the cells were
exposed to substances for 48 hr before being
harvested and analyzed for effects on gene
expression. Triplicate samples of each con-
centration ofcompounds were used in the
experiments.
Toxicity was assessed by microscopic
evaluation of cell morphology and by the
CellTiter 96 cell proliferation assay in
cl1 Cl
which the mitochondrial formation of a
colored tetrazolium salt is measured spec-
trophotometrically at 492 nm (14). In the
assay, absorbance is directly proportional to
the number ofliving cells in each culture.
Assayfor humanpla*entalalkalinephos-
phatase. Conditioned medium was analyzed
for the relative levels ofplacental alkaline
phosphatase (ALP) reporter protein expressed
and secreted from the GRAF reporter cells by
a chemiluminescent assay. A 10-p1 aliquot of
the conditioned cell culture medium was
mixed with 200 pl of assay buffer (10 mM
diethanolamine, pH 10.0; 1 mM MgC12; and
0.5 mM AMPPD) in white microtiter plates
and incubated for 20 min at 37°C before
being transferred to a microplate format lumi-
nometer (Luminoskan; Labsystems, Helsinki,
Finland). Theluminometerwas set onintegral
measurement with 1 sec reading ofeach well.
The ALP activity was expressed in light units
(LU), which are directly proportional to the
levelofALPsecreted fromthecells.
Results
The ability of the xenobiotics to compete
with 3H-dexamethasone for binding to
human GR is shown in Figure 1. 3-MeSO2-
CB149 (Fig. 2) almost completely removed
dexamethasone from GR at a concentration
of 10 pM, with an IC50 (concentration that
inhibits 50%) ofapproximately 1 pM. The
IC50ofunlabeleddexamethasonewas approx-
imately 6 nM. Also 3-MeSO2-CBO1I affect-
ed binding of dexamethasone to GR,
althoughwith arelativeaffinityapproximately
10-fold lower than that of3-MeSO2-CBI49.
3-MeSO2-DDE did notbind tohuman GR.
None of the three xenobiotics activated
the GRin GRAF cells (measured asinduction
28
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20
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Figure 2. The chemical structures of 3-MeSO2-
CB149 and 4-MeSO2-CB149. A methyl sulfone
group in the 4 position instead of the 3 position
increases the affinity to mouse glucocorticoid
receptor (GR). Other important structures for bind-
ing to GR seem to be three ortho-chlorines in the
2,6,2'-positions and a chlorine in the 4' position.
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Figure 3. Effect of 3-MeSO2-CBI149, 3-MeSO2-
CB101, and 3-MeSO -DDE on the induction of
alkalinephosphataseiALP) by dexamethasone in
GRAF cells. The concentration of 10-10 M in the
graph represents the absence of methyl sulfone,
i.e., exposure to 5 nM dexamethasone in the pres-
ence of solvent only. No signs of toxicity were
observed at the concentrations shown in the fig-
ure. Each point represents mean ± standard devi-
ation oftriplicate samples.
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of; ALP; data not shown). The effective con-
centration (EC50) for dexamethasone was 4.6
nM. The ability ofthexenobiotics to blockthe
dexamethasone-mediated effect was studied
next. 3-MeSO2-CB149 completely inhibited
dexamethasone-mediated induction ofALP,
with an IC50 of 2.7 pM (Fig. 3). 3-MeSO2-
DDE decreased ALP at 10 pM, but a very
steep dose- response curve and severe signs of
toxicity at 25 pM make interpretation ofthese
data difficult (data not shown). Finally, 3-
MeSO2-CB101 had no effect on the dexam-
ethasone-dependent induction ofALP.
To assess the nature of the inhibitory
effect of the xenobiotics on GR-mediated
induction ofALP, the effect of the xenobi-
otics was compared with that of RU486, a
competitive antagonist to GR. As shown in
Figure 4A, RU486 competitively antago-
nized the effect ofdexamethasone (RU486
dose-dependently increased the EC50 ofdex-
amethasone, but did not affect the maxi-
mum induction mediated by dexametha-
sone). 3-MeSO2-CB149 also dose-depen-
dently increased the EC50 of dexametha-
sone, indicating a competitive antagonism
(Fig. 4B). However, maximum induction by
dexamethasone was affected at 5 pM, show-
ing a mixed type of antagonism at higher
exposure levels. 3-MeSO2-DDE showed a
high toxicity at 10 pM, implying that toxici-
ty is probably the cause ofthe noncompeti-
tive antagonism seen at 5 pM (data not
shown). 3-MeSO2-CB101 (0.5-5 pM) did
not antagonize the effect ofdexamethasone.
The binding of 3-MeSO2-CB149 to
GR led us to screen 24 methylsulfonyl
PCBs for their affinity to GR in mouse liver
cytosol. As shown in Table 1, several
methylsulfonyl PCBs bound to GR with a
higher affinity than did 3-MeSO2-CB149.
The effect ofone ofthe potent methyl sul-
fones, 4-MeSO2-CB149 (IC50 15 PM; see
Fig. 2 for structure), is shown in Figure 5
together with effects of 3-MeSO2-CB149
(IC50 >30 pM), the endogenous substrate
corticosterone (IC5040 nM), and unlabeled
dexamethasone (IC50 10 nM). 3-MeSO2-
DDE did not compete with dexamethasone
for binding to mouse GR (data notshown).
Discussion
The present study shows that the PCB
methyl sulfone 3-MeSO2-CB149 has an
aifinity to human GR and appears to com-
petitively antagonize the effects of the
endogenous hormone, similarly to the drug
RU486. When comparing 3-MeSO2-CB149
with RU486, the relative affinity of 3-
MeSO2-CB149 to GR (IC50 = 1 pM) is
almost 1,000-fold less than that of RU486
(data not shown). Still, 3-MeSO2-CB149
was active in GRAF cells at a concentration
of500 nM. The inhibitory effect of2-5 pM
3-MeSO2-CB149 on dexamethasone-depen-
dent ALP induction in cells was comparable
to that of 10 nM RU486, indicating that the
potency in cells of 3-MeSO2-CB149 is
200-500 times less than that of RU486.
However, 3-MeSO2-CB149 may not be the
most potent PCB methyl sulfone, as indicat-
ed by a fourfold higher affinity of4-MeSO2-
CB149 than of3-MeSO2-CB149 to mouse
GR Considering the high in vivopersistency
of3-MeSO2-CB149, in contrast to the fairly
rapid metabolism of RU486 (tl2= 20 hr in
man) (15) we suspect that the difference in
biological potency between these compounds
in vivois less than thatobserved in vitro.
IC50values of1 pM forthe binding of3-
MeSO2-CB149 to human GR (cellular
extract) and of 15 pM for the binding of4-
MeSO2-CB149 to mouse GR (liver cytosol)
maynot seem impressive in comparisonwith
IC50 values of drugs such as RU486.
However, these values are comparable to
IC50 values reported for the interaction
between other xenobiotics and the sex hor-
mone receptors (16,1X].
The difference in IC 0 values between
GRAF cells and mouse fiver cytosol may,
to some extent, be caused by species differ-
ences. Another plausible explanation is the
higher protein concentration in the liver
cytosol than in the GRAF cell extract.
Because lipophilic xenobiotics in an aque-
ous solution interact with macromolecules,
the concentration of free xenobiotics may
be lower in the cytosolic fraction than in
the GRAF cell extract and, consequently, a
higher concentration ofxenobiotics may be
needed for an equal effect.
The comparison of affinities of 24
methylsulfonyl PCBs to mouse GR enables
us to speculate on structure-activity relation-
ships. Itseems thatonlymethylsulfonyl PCBs
with three chlorines in ortho-positions
(2,6,2') bind to GR. As judged from IC25
values of the 4 pairs of 3- and 4-substituted
methylsulfonyl PCBs, amethylsulfonyl group
in the 4-position relative to the 3-position
increases the affinity roughly by a factor of
two. Because all thesecompounds also have a
chlorine in the 4'-position, this appears to be
an important structural determinant for
binding. Thus, it seems that amethylsulfonyl
PCB shouldcontain three ortho-chlorines and
be as extended as possible, with a 4'-chlorine
on one end and a methylsulfonyl group on
the other 4-position for maximal binding
affinity to mouse GR
Methyl sulfone metabolites ofPCBs are as
widespread and persistent as the parent PCBs
(18), making them a potential hazard to
humans and animals worldwide. For example,
16 different PCB methyl sulfones and 1 DDE
methyl sulfone are present in mother's milk in
Sweden, with 4-MeSO2-CB149 being the
most abundant and 3-MeSO2-CB149 being
the third most abundant methyl sulfone. The
concentration of these two compounds in
pooled milk was 0.6 ng/g (lipid weight) in
43U
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Figure 4. Effect of (A) RU486 and (B) 3-CB149 on the
induction of alkaline phosphatase (ALP) in GRAF
cells by increasing concentrations of dexametha-
sone (Dex). Effects on cell morphology were
observed in cells exposed to 5 pM 3-MeSO2-CB149.
The concentration of10-12 M inthe graph represents
absence of dexamethasone. Each point represents
mean ± standard deviation oftriplicate samples.
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Figure 5. Competition binding studies to the
mouse glucocorticoid receptor (GR). Receptor (1
nmol) was incubated overnight with 3H-dexam-
ethasone and either 3-MeSO2-CB149, 4-MeSO2-
CB149, corticosterone, or unlabeled dexametha-
sone (Dex) after which 3H-dexamethasone bound
to GR was quantified. Each point represents mean
of duplicate samples.
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most abundant and 3-MeSO2-CB149 being
the third most abundant methyl sulfone. The
concentration of these two compounds in
pooled milk was 0.6 ng/g (lipid weight) in
1992 (19). Much higher concentrations of
PCB methyl sulfones have been found, for
example, in Baltic seals (20), suggesting that
some species are more subject to biological
effects ofPCB methyl sulfones than humans.
Total PCB methyl sulfone concentrations of
110 pg/g (lipid weight) have been found in
the blubber ofgray seals, where 3-MeSO2-
CB149 is the most abundant (5). The PCB
methyl sulfones accumulate in liver relative to
blubber in gray seals (5); therefore, these ani-
mals may be exposed to even higher concen-
trations ofPCB methyl sulfones. The disease
syndrome in Baltic seals (4) indicates an inter-
ference with the glucocorticoid homeostasis.
There are also other indications of environ-
mental pollutants acting on the glucocorticoid
system. Field studies showed a reduced ability
offish from polluted waters to elevate cortisol
levels in response to acute stress (21,22).
Likewise, DDT and corticosterone induced a
similar pathological development in amphib-
ians, which was interpreted as a potential cor-
ticosterone-mimicking action ofDDT (23).
In conclusion, several PCB methyl sul-
fones have affinity to GR, which may affect
the glucocorticoid homeostasis. Therefore,
the concern for endocrine disruptors
should also be directed towards the gluco-
corticoid system.
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